A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
Future oncology (London, England), cilt.22, sa.11, ss.1247-1262, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 22 Sayı: 11
- Basım Tarihi: 2026
- Doi Numarası: 10.1080/14796694.2026.2652543
- Dergi Adı: Future oncology (London, England)
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.1247-1262
- Anahtar Kelimeler: EGFR-mutated, Non-small cell lung cancer, Osimertinib, Plain language review, Stage III, Unresectable
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet